Clearwater advises Armira on raising finance to support its partnership with almapharm
We have advised Armira Beteiligungen GmbH & Co. KG (Armira) on raising finance to support their partnership with almapharm GmbH + Co. KG (almapharm), one of Germany’s leading companies in animal nutraceuticals.
almapharm, headquartered in Wildpoldsried in the Allgäu region, develops and produces nutraceuticals in the form of healthy food additives for disease prevention and establishes pharmaceutical products for anti-bacterial and anti-inflammatory applications. The company focuses on natural, quality-tested, and certified active ingredients, offering an extensive range of more than 100 nutraceuticals with a broad range of applications.
Munich-based Armira is a leading investment holding company focusing on direct equity investments in medium-sized, profitable family businesses and ambitious growth companies in the DACH region, Northern Italy, and beyond. Armira is backed by an exclusive investor base of families, entrepreneurs, and entrepreneurial capital, fostering trusted partnerships with a long-term horizon.
Clearwater’s expertise and commitment to securing the best financing structure was instrumental. We are extremely pleased with their performance and look forward to working together again on future transactions.
We are delighted to have supported Armira in securing the financing for their partnership with almapharm. It was a pleasure to leverage our expertise in a competitive market to deliver multiple financing options and ultimately achieve a successful outcome for Armira.